Dr. Paul Terasaki established the Nibei Foundation, a California non-profit organization, in 1998. His vision included providing various forms of support to medical researchers and physicians coming from Japan to engage in medical activities at United States institutions. Since May, 2002, the researchers, physicians, their families, and local friends have attended a variety of cultural, informative classes directed by Japanese Americans. The Foundation has become a hub of cultural exchanges for people with deep, fond roots in America and Japan.

1964: He developed the micro lymphocytotoxicity test.

1970: The micro lymphocytotoxicity test was adopted as the international standard method of tissue typing.

1968-1984: Tissue typing trays were supplied to the transplant community by his UCLA laboratory, and after 1984 by One Lambda, which is a private company he established.

1969-1999: Professor of Surgery at UCLA.

2000: TFL (Terasaki Foundation Laboratory) was established to develop therapy for cancer


Presidential roles:

• The International Histocompatibility Society

• The International Transplant Society

• The American Society of Histocompatibility and Immunogenetics

Honors & Awards:

• The Medawar Prize from the International Transplant Society

• The Karl Landsteiner and Emily Cooly Award from the American Association of Blood Banks

• The Phillip Levine Award from the American Society of Clinical Pathologists

Publication: Over 800 articles